Brawn Biotech

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE899B01015
  • NSEID:
  • BSEID: 530207
INR
20.25
-0.74 (-3.53%)
BSENSE

Nov 20

BSE+NSE Vol: 10

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 479596,
    "name": "Brawn Biotech",
    "stock_name": "Brawn Biotech",
    "full_name": "Brawn Biotech Ltd",
    "name_url": "stocks-analysis/brawn-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "20.25",
    "chg": -0.74,
    "chgp": "-3.53%",
    "dir": -1,
    "prev_price": "20.99",
    "mcapval": "6.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530207,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE899B01015",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "10 ",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/brawn-biotech-479596-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Brawn Biotech Ltd Hits New 52-Week High of Rs 26.64 on Back of Strong Technical Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/brawn-biotech-ltd-hits-new-52-week-high-at-rs2664-4242199",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BrawnBiotechLtd_priceRelatedfactors_4242199.png",
        "date": "2026-10-28 10:43:03",
        "description": "From a 52-week low of Rs 17.71 to a fresh high of Rs 26.64, Brawn Biotech Ltd has delivered a 33.2% gain over the past year, significantly outperforming the Sensex which declined 14% in the same period. This rally, culminating in a new 52-week peak on 28 Oct 2026, is underpinned by a broad alignment of technical indicators signalling sustained momentum."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Brawn Biotech Ltd to 52-Week High of Rs 25.7",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/brawn-biotech-ltd-hits-new-52-week-high-at-rs257-4216268",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BrawnBiotechLtd_priceRelatedfactors_4216268.png",
        "date": "2026-10-06 10:35:14",
        "description": "Surging to a fresh 52-week high of Rs 25.7 on 6 Oct 2026, Brawn Biotech Ltd has demonstrated notable price momentum, outperforming its sector despite a modest underperformance on the day. This milestone caps a year-long rally that has delivered a 14.22% return, comfortably ahead of the Sensex’s 11.13% decline over the same period."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Brawn Biotech Ltd to 52-Week High of Rs 24.74",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/brawn-biotech-ltd-hits-new-52-week-high-at-rs2474-4211251",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BrawnBiotechLtd_priceRelatedfactors_4211251.png",
        "date": "2026-10-01 10:43:26",
        "description": "With a decisive surge to Rs 24.74 on 1 Oct 2026, Brawn Biotech Ltd has reached a fresh 52-week high, marking a notable milestone in its price momentum. This rally has been fuelled by a confluence of bullish technical indicators and sustained gains over the past three sessions, even as the broader market struggles to find footing."
      }
    ],
    "total": 14,
    "sid": "479596",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/brawn-biotech-479596"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Nov-2026",
      "details": "NEWSPAPER PUBLICATION FOR UN-AUDITED FINANCIAL RESULTS FOR QUARTER AND HALF YEAR ENDED 30TH SEP 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 5Th November 2026 To Consider And Approve Inter-Alia Un-Audited Financial Results Of The Company For Quarter Ended September 30 2026.",
      "datetime": "05-Nov-2026",
      "details": "Outcome Of Board Meeting Held On 5th November 2026 To Consider And Approve Inter-Alia Un-Audited Financial Results Of The Company For Quarter Ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Regarding Non-Applicability Of Regulation 23(9)",
      "datetime": "05-Nov-2026",
      "details": "Intimation regarding non-applicability of regulation 23(9)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Brawn Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 12 Sep 18",
          "dt": "2018-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-Nov-2026 | Source : BSE

NEWSPAPER PUBLICATION FOR UN-AUDITED FINANCIAL RESULTS FOR QUARTER AND HALF YEAR ENDED 30TH SEP 2026

Board Meeting Outcome for Outcome Of Board Meeting Held On 5Th November 2026 To Consider And Approve Inter-Alia Un-Audited Financial Results Of The Company For Quarter Ended September 30 2026.

05-Nov-2026 | Source : BSE

Outcome Of Board Meeting Held On 5th November 2026 To Consider And Approve Inter-Alia Un-Audited Financial Results Of The Company For Quarter Ended September 30 2026.

Intimation Regarding Non-Applicability Of Regulation 23(9)

05-Nov-2026 | Source : BSE

Intimation regarding non-applicability of regulation 23(9)

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Brawn Biotech Ltd has declared 10% dividend, ex-date: 12 Sep 18

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available